International Journal of Hematology

, Volume 76, Supplement 1, pp 169–170 | Cite as

Bone marrow transplantation for non-malignant disease

  • Keith M Sullivan
Recent Advances in Hematopoietic Stem Cell Transplantation


Hematopoietic Stem Cell Transplantation Sickle Cell Disease Aplastic Anemia Thalassemia Osteogenesis Imperfecta 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Sullivan KM, Parkman R, Walters MC. Bone marrow tansplantation for non-malignant disease.Hematology (Am Soc Hematol Educ Prog). 2000;2000:319–338.Google Scholar
  2. 2.
    Buckley RH, Schiff SE, Schiff RI, et al. Hematopoietic stem cell transplantation for the treatment of severe combined immunodeficiency.N Engl J Med. 1999;340:508–516.PubMedCrossRefGoogle Scholar
  3. 3.
    Aiuti A, Slavin S, Aker M, et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.Science. 2002;296:2410–2413.PubMedCrossRefGoogle Scholar
  4. 4.
    Horwitz EM, Gordon PL, Koo WK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implication for cell therapy of bone.Proc Natl Acad Sci USA. 2002;99: 8932–8937.PubMedCrossRefGoogle Scholar
  5. 5.
    Georges GE, Storb R. Stem cell transplantation for aplastic anemia.Int J Hematol. 2002;75:141–146.PubMedCrossRefGoogle Scholar
  6. 6.
    Sullivan KM, Walters MC, Patience M, et al. Collaborative study of marrow transplantation for sickle cell disease: aspects specific for transplantation of hemoglobin disorders.Bone Marrow Transplant. 1997;19:102–105.Google Scholar
  7. 7.
    Lucarelli G, Galimberti M, Giardini C, et al. Bone marrow transplantation in thalassemia: the experience of Persaro.Ann NY Acad Sci. 1998;850:270–275.PubMedCrossRefGoogle Scholar
  8. 8.
    Walters MC, Storb R, Patience M, et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report.Blood. 2000;95:1918–1924.PubMedGoogle Scholar
  9. 9.
    Walters MC, Patience M, Leisenring W, et al. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood MarrowTransplant. 2001;7: 665–673.PubMedCrossRefGoogle Scholar
  10. 10.
    Sullivan KM, Furst DE. The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases.J Rheumatol. 1997;48:1–4.Google Scholar
  11. 11.
    Brodsky RA. High-dose cyclophosphamide for aplastic anemia and autoimmunity.Curr Opin Oncol. 2002;14:143–146.PubMedCrossRefGoogle Scholar
  12. 12.
    McSweeney PA, Nash RA, Sullivan KM, et al. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.Blood. in press.Google Scholar

Copyright information

© The Japanese Society of Hematology 2002

Authors and Affiliations

  • Keith M Sullivan
    • 1
  1. 1.Division of Medical Oncology and TransplantationDuke University Medical CenterDurhamUSA

Personalised recommendations